Is NCT03127189 results overdue?

Yes — results are overdue. Primary completion was 2018-04-10; the FDAAA-801 reporting deadline (2019-04-10) passed 2675 days ago and no results are posted on ClinicalTrials.gov.

A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants

NCT ID	NCT03127189 ↗
Sponsor	Janssen Research & Development, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-04-10 (ACTUAL)
Reporting deadline	2019-04-10 (completion + 365d)
Days overdue	2675
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `7a7f5cf8317a8869…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03127189. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.